COMBINATION PRODUCTS WITH TYROSINE KINASE INHIBITORS AND THEIR USE

The present invention relates to pharmaceutical products comprising a combination of (i) a MET inhibitor and (ii) an EGFR inhibitor, or a pharmaceutically acceptable salt thereof, respectively, or a prodrug thereof, which are jointly active in the treatment of proliferative diseases, corresponding p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Peng, Bin, Ito, Moriko, Gong, Ying, Akimov, Mikhail, Chatenay-Rivauday, Christian, Ralph, Tiedt
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Peng, Bin
Ito, Moriko
Gong, Ying
Akimov, Mikhail
Chatenay-Rivauday, Christian
Ralph, Tiedt
description The present invention relates to pharmaceutical products comprising a combination of (i) a MET inhibitor and (ii) an EGFR inhibitor, or a pharmaceutically acceptable salt thereof, respectively, or a prodrug thereof, which are jointly active in the treatment of proliferative diseases, corresponding pharmaceutical formulations, uses, methods, processes, commercial packages and related invention embodiments.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3964513A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3964513A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3964513A13</originalsourceid><addsrcrecordid>eNrjZHBy9vd18vRzDPH091MICPJ3CXUOCVYI9wzxUAiJDPIP9vRzVfAGyge7Knj6eXg6eYb4BwUrOPq5KIR4uHoGKYQGu_IwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUknjXAGNLMxNTQ2NHQ2MilAAA2TgrIQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMBINATION PRODUCTS WITH TYROSINE KINASE INHIBITORS AND THEIR USE</title><source>esp@cenet</source><creator>Peng, Bin ; Ito, Moriko ; Gong, Ying ; Akimov, Mikhail ; Chatenay-Rivauday, Christian ; Ralph, Tiedt</creator><creatorcontrib>Peng, Bin ; Ito, Moriko ; Gong, Ying ; Akimov, Mikhail ; Chatenay-Rivauday, Christian ; Ralph, Tiedt</creatorcontrib><description>The present invention relates to pharmaceutical products comprising a combination of (i) a MET inhibitor and (ii) an EGFR inhibitor, or a pharmaceutically acceptable salt thereof, respectively, or a prodrug thereof, which are jointly active in the treatment of proliferative diseases, corresponding pharmaceutical formulations, uses, methods, processes, commercial packages and related invention embodiments.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220309&amp;DB=EPODOC&amp;CC=EP&amp;NR=3964513A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25544,76295</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220309&amp;DB=EPODOC&amp;CC=EP&amp;NR=3964513A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Peng, Bin</creatorcontrib><creatorcontrib>Ito, Moriko</creatorcontrib><creatorcontrib>Gong, Ying</creatorcontrib><creatorcontrib>Akimov, Mikhail</creatorcontrib><creatorcontrib>Chatenay-Rivauday, Christian</creatorcontrib><creatorcontrib>Ralph, Tiedt</creatorcontrib><title>COMBINATION PRODUCTS WITH TYROSINE KINASE INHIBITORS AND THEIR USE</title><description>The present invention relates to pharmaceutical products comprising a combination of (i) a MET inhibitor and (ii) an EGFR inhibitor, or a pharmaceutically acceptable salt thereof, respectively, or a prodrug thereof, which are jointly active in the treatment of proliferative diseases, corresponding pharmaceutical formulations, uses, methods, processes, commercial packages and related invention embodiments.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHBy9vd18vRzDPH091MICPJ3CXUOCVYI9wzxUAiJDPIP9vRzVfAGyge7Knj6eXg6eYb4BwUrOPq5KIR4uHoGKYQGu_IwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUknjXAGNLMxNTQ2NHQ2MilAAA2TgrIQ</recordid><startdate>20220309</startdate><enddate>20220309</enddate><creator>Peng, Bin</creator><creator>Ito, Moriko</creator><creator>Gong, Ying</creator><creator>Akimov, Mikhail</creator><creator>Chatenay-Rivauday, Christian</creator><creator>Ralph, Tiedt</creator><scope>EVB</scope></search><sort><creationdate>20220309</creationdate><title>COMBINATION PRODUCTS WITH TYROSINE KINASE INHIBITORS AND THEIR USE</title><author>Peng, Bin ; Ito, Moriko ; Gong, Ying ; Akimov, Mikhail ; Chatenay-Rivauday, Christian ; Ralph, Tiedt</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3964513A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Peng, Bin</creatorcontrib><creatorcontrib>Ito, Moriko</creatorcontrib><creatorcontrib>Gong, Ying</creatorcontrib><creatorcontrib>Akimov, Mikhail</creatorcontrib><creatorcontrib>Chatenay-Rivauday, Christian</creatorcontrib><creatorcontrib>Ralph, Tiedt</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Peng, Bin</au><au>Ito, Moriko</au><au>Gong, Ying</au><au>Akimov, Mikhail</au><au>Chatenay-Rivauday, Christian</au><au>Ralph, Tiedt</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMBINATION PRODUCTS WITH TYROSINE KINASE INHIBITORS AND THEIR USE</title><date>2022-03-09</date><risdate>2022</risdate><abstract>The present invention relates to pharmaceutical products comprising a combination of (i) a MET inhibitor and (ii) an EGFR inhibitor, or a pharmaceutically acceptable salt thereof, respectively, or a prodrug thereof, which are jointly active in the treatment of proliferative diseases, corresponding pharmaceutical formulations, uses, methods, processes, commercial packages and related invention embodiments.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP3964513A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title COMBINATION PRODUCTS WITH TYROSINE KINASE INHIBITORS AND THEIR USE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T10%3A10%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Peng,%20Bin&rft.date=2022-03-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3964513A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true